US packaged food producers are slashing prices to counter stagnating sales driven by inflation, growing health consciousness, and a backlash against processed foods. According to the Financial Times, consumers are increasingly avoiding snack aisles due to rising costs and heightened awareness of health risks linked to processed foods. This shift has forced companies to prioritize affordability over premium pricing strategies, with many introducing discounted product lines and promotional bundles to lure budget-conscious buyers. Anti-obesity drugs like Wegovy and Ozempic have further dented demand, as consumers prioritize weight-loss solutions over indulgent snacks.